Point72 Asset Management »

Aspire Biopharma Hldgs shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Aspire Biopharma Hldgs (ASBP) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Aspire Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9k 14k 0.13

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Aspire Biopharma Hldgs

UBS Group
Crewe Advisors
Jane Street
Vanguard Group
Optivise Advisory Services
XTX Topco
Geode Capital Management
Procyon Private Wealth Partners
Antara Capital
Resolute Advisors
Three Seasons Wealth
Virtu Financial
VR Advisory Services
Verition Fund Management
EP Wealth Advisors

View all funds holding Aspire Biopharma Hldgs